Bayer AG
26 products tracked · names used in filings: Bayer AG, Bayer Pharma AG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 17 Nov 2025🇪🇺 EU approval (EC decision)
Lynkuet (elinzanetant) approved in the EU
Marketing authorisation to Bayer AG; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Aliqopa copanlisib | Application withdrawn | |
| 🇪🇺 | Lynkuet elinzanetant | Authorised | 2025-11-17 |
| 🇪🇺 | Beyonttra acoramidis | Authorised | 2025-02-10 |
| 🇪🇺 | Kerendia finerenone | Authorised | 2022-02-16 |
| 🇪🇺 | Verquvo vericiguat | Authorised | 2021-07-16 |
| 🇪🇺 | Nubeqa darolutamide | Authorised | 2020-03-27 |
| 🇪🇺 | Vitrakvi larotrectinib | Authorised | 2019-09-19 |
| 🇪🇺 | Jivi damoctocog alfa pegol | Authorised | 2018-11-22 |
| 🇪🇺 | Iblias octocog alfa | Withdrawn | 2016-02-18 |
| 🇪🇺 | Kovaltry octocog alfa | Authorised | 2016-02-18 |
| 🇪🇺 | Adempas riociguat | Authorised | 2014-03-27 |
| 🇪🇺 | Xofigo radium Ra223 dichloride | Authorised | 2013-11-13 |
| 🇪🇺 | Stivarga regorafenib | Authorised | 2013-08-26 |
| 🇪🇺 | Eylea aflibercept | Authorised | 2012-11-21 |
| 🇪🇺 | Xarelto rivaroxaban | Authorised | 2008-09-30 |
| 🇪🇺 | Nexavar sorafenib | Authorised | 2006-07-19 |
| 🇪🇺 | Ventavis iloprost | Authorised | 2003-09-15 |
| 🇪🇺 | Levitra vardenafil | Authorised | 2003-03-06 |
| 🇪🇺 | Vivanza vardenafil | Withdrawn | 2003-03-04 |
| 🇪🇺 | PritorPlus telmisartan;hydrochlorothiazide | Withdrawn | 2002-04-22 |
| 🇪🇺 | Kinzalkomb telmisartan;hydrochlorothiazide | Withdrawn | 2002-04-19 |
| 🇪🇺 | Kogenate Bayer octocog alfa | Lapsed | 2000-08-04 |
| 🇪🇺 | Helixate NexGen octocog alfa | Withdrawn | 2000-08-04 |
| 🇪🇺 | Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG) telmisartan | Withdrawn | 1998-12-16 |
| 🇪🇺 | Pritor telmisartan | Withdrawn | 1998-12-11 |
| 🇪🇺 | Betaferon interferon beta-1b | Authorised | 1995-11-30 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.